Stay updated with breaking news from Nasdaq Tcon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other analysts have also weighed in on the stock. Jonestrading reiterated a hold rating on shares of TRACON Pharmaceuticals in a research note on Monday, […]
StockNews.com assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently weighed in on TCON. HC Wainwright reissued a buy rating and set a $7.00 price objective on shares of TRACON […]
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts also recently weighed in on the stock. Jonestrading reissued a hold rating on shares of TRACON Pharmaceuticals in a report […]
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) – Analysts at HC Wainwright increased their FY2023 earnings estimates for shares of TRACON Pharmaceuticals in a note issued to investors on Monday, November 20th. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company will post earnings of ($0.02) per share for the year, up from […]
HC Wainwright reaffirmed their buy rating on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $7.00 target price on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for TRACON Pharmaceuticals’ Q4 2023 earnings at ($0.03) EPS, FY2023 earnings at ($0.02) […]